Cargando…
Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence
BACKGROUND: Viral diversity and abundance are defining properties of human immunodeficiency virus (HIV)-1's biology and pathogenicity. Despite the increasing availability of antiretroviral therapy, HIV-associated dementia (HAD) continues to be a devastating consequence of HIV-1 infection of the...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123635/ https://www.ncbi.nlm.nih.gov/pubmed/21645334 http://dx.doi.org/10.1186/1742-4690-8-44 |
_version_ | 1782207008633520128 |
---|---|
author | Na, Hong Acharjee, Shaona Jones, Gareth Vivithanaporn, Pornpun Noorbakhsh, Farshid McFarlane, Nicola Maingat, Ferdinand Ballanyi, Klaus Pardo, Carlos A Cohen, Éric A Power, Christopher |
author_facet | Na, Hong Acharjee, Shaona Jones, Gareth Vivithanaporn, Pornpun Noorbakhsh, Farshid McFarlane, Nicola Maingat, Ferdinand Ballanyi, Klaus Pardo, Carlos A Cohen, Éric A Power, Christopher |
author_sort | Na, Hong |
collection | PubMed |
description | BACKGROUND: Viral diversity and abundance are defining properties of human immunodeficiency virus (HIV)-1's biology and pathogenicity. Despite the increasing availability of antiretroviral therapy, HIV-associated dementia (HAD) continues to be a devastating consequence of HIV-1 infection of the brain although the underlying disease mechanisms remain uncertain. Herein, molecular diversity within the HIV-1 non-structural gene, Vpr, was examined in RNA sequences derived from brain and blood of HIV/AIDS patients with or without HIV-associated dementia (HAD) together with the ensuing pathobiological effects. RESULTS: Cloned brain- and blood-derived full length vpr alleles revealed that amino acid residue 77 within the brain-derived alleles distinguished HAD (77Q) from non-demented (ND) HIV/AIDS patients (77R) (p < 0.05) although vpr transcripts were more frequently detected in HAD brains (p < 0.05). Full length HIV-1 clones encoding the 77R-ND residue induced higher IFN-α, MX1 and BST-2 transcript levels in human glia relative to the 77Q-HAD encoding virus (p < 0.05) but both viruses exhibited similar levels of gene expression and replication. Myeloid cells transfected with 77Q-(pVpr77Q-HAD), 77R (pVpr77R-ND) or Vpr null (pVpr((-)))-containing vectors showed that the pVpr77R-ND vector induced higher levels of immune gene expression (p < 0.05) and increased neurotoxicity (p < 0.05). Vpr peptides (amino acids 70-96) containing the 77Q-HAD or 77R-ND motifs induced similar levels of cytosolic calcium activation when exposed to human neurons. Human glia exposed to the 77R-ND peptide activated higher transcript levels of IFN-α, MX1, PRKRA and BST-2 relative to 77Q-HAD peptide (p < 0.05). The Vpr 77R-ND peptide was also more neurotoxic in a concentration-dependent manner when exposed to human neurons (p < 0.05). Stereotaxic implantation of full length Vpr, 77Q-HAD or 77R-ND peptides into the basal ganglia of mice revealed that full length Vpr and the 77R-ND peptide caused greater neurobehavioral deficits and neuronal injury compared with 77Q-HAD peptide-implanted animals (p < 0.05). CONCLUSIONS: These observations underscored the potent neuropathogenic properties of Vpr but also indicated viral diversity modulates innate neuroimmunity and neurodegeneration. |
format | Online Article Text |
id | pubmed-3123635 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31236352011-06-26 Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence Na, Hong Acharjee, Shaona Jones, Gareth Vivithanaporn, Pornpun Noorbakhsh, Farshid McFarlane, Nicola Maingat, Ferdinand Ballanyi, Klaus Pardo, Carlos A Cohen, Éric A Power, Christopher Retrovirology Research BACKGROUND: Viral diversity and abundance are defining properties of human immunodeficiency virus (HIV)-1's biology and pathogenicity. Despite the increasing availability of antiretroviral therapy, HIV-associated dementia (HAD) continues to be a devastating consequence of HIV-1 infection of the brain although the underlying disease mechanisms remain uncertain. Herein, molecular diversity within the HIV-1 non-structural gene, Vpr, was examined in RNA sequences derived from brain and blood of HIV/AIDS patients with or without HIV-associated dementia (HAD) together with the ensuing pathobiological effects. RESULTS: Cloned brain- and blood-derived full length vpr alleles revealed that amino acid residue 77 within the brain-derived alleles distinguished HAD (77Q) from non-demented (ND) HIV/AIDS patients (77R) (p < 0.05) although vpr transcripts were more frequently detected in HAD brains (p < 0.05). Full length HIV-1 clones encoding the 77R-ND residue induced higher IFN-α, MX1 and BST-2 transcript levels in human glia relative to the 77Q-HAD encoding virus (p < 0.05) but both viruses exhibited similar levels of gene expression and replication. Myeloid cells transfected with 77Q-(pVpr77Q-HAD), 77R (pVpr77R-ND) or Vpr null (pVpr((-)))-containing vectors showed that the pVpr77R-ND vector induced higher levels of immune gene expression (p < 0.05) and increased neurotoxicity (p < 0.05). Vpr peptides (amino acids 70-96) containing the 77Q-HAD or 77R-ND motifs induced similar levels of cytosolic calcium activation when exposed to human neurons. Human glia exposed to the 77R-ND peptide activated higher transcript levels of IFN-α, MX1, PRKRA and BST-2 relative to 77Q-HAD peptide (p < 0.05). The Vpr 77R-ND peptide was also more neurotoxic in a concentration-dependent manner when exposed to human neurons (p < 0.05). Stereotaxic implantation of full length Vpr, 77Q-HAD or 77R-ND peptides into the basal ganglia of mice revealed that full length Vpr and the 77R-ND peptide caused greater neurobehavioral deficits and neuronal injury compared with 77Q-HAD peptide-implanted animals (p < 0.05). CONCLUSIONS: These observations underscored the potent neuropathogenic properties of Vpr but also indicated viral diversity modulates innate neuroimmunity and neurodegeneration. BioMed Central 2011-06-06 /pmc/articles/PMC3123635/ /pubmed/21645334 http://dx.doi.org/10.1186/1742-4690-8-44 Text en Copyright ©2011 Na et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Na, Hong Acharjee, Shaona Jones, Gareth Vivithanaporn, Pornpun Noorbakhsh, Farshid McFarlane, Nicola Maingat, Ferdinand Ballanyi, Klaus Pardo, Carlos A Cohen, Éric A Power, Christopher Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence |
title | Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence |
title_full | Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence |
title_fullStr | Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence |
title_full_unstemmed | Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence |
title_short | Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence |
title_sort | interactions between human immunodeficiency virus (hiv)-1 vpr expression and innate immunity influence neurovirulence |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123635/ https://www.ncbi.nlm.nih.gov/pubmed/21645334 http://dx.doi.org/10.1186/1742-4690-8-44 |
work_keys_str_mv | AT nahong interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence AT acharjeeshaona interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence AT jonesgareth interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence AT vivithanapornpornpun interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence AT noorbakhshfarshid interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence AT mcfarlanenicola interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence AT maingatferdinand interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence AT ballanyiklaus interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence AT pardocarlosa interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence AT cohenerica interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence AT powerchristopher interactionsbetweenhumanimmunodeficiencyvirushiv1vprexpressionandinnateimmunityinfluenceneurovirulence |